Finepoint Capital LP Portfolio Holdings

Finepoint Capital LP

$1.18 Billion
Q4 2024

Finepoint Capital LP has filed its 13F form on February 13, 2025 for Q4 2024 where it was disclosed a total value porftolio of $1.18 Billion distributed in 26 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Liberty Broadband Corp with a value of $151M, Argenx Se with a value of $32.6M, Revolution Medicines, Inc. with a value of $31.1M, Spring Works Therapeutics, Inc. with a value of $27.1M, and Ascendis Pharma A/S with a value of $25.5M.

Examining the 13F form we can see an increase of $218M in the current position value, from $963M to 1.18B.

Finepoint Capital LP is based out at Boston, MA

Below you can find more details about Finepoint Capital LP portfolio as well as his latest detailed transactions.

Portfolio value $1.18 Billion

ETFs: $771 Million

Healthcare: $260 Million

Communication Services: $151 Million

Financial Services: $22,000

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
LBRDK Liberty Broadband Corp Communication Services	$10.7B	$151 Million 12.76% of portfolio	2,015,710	Q4 2024 Added 1.06%
ARGX Argenx Se Healthcare	$35.7B	$32.6 Million 2.76% of portfolio	52,928	Q4 2024 Reduced 2.76%

Summary

Portfolio
No. of Stocks 26
Current Value $1.18 Billion
Prior Value $963 Million
Filing
Period Q4 2024
Filing Date February 13, 2025
Form Type 13F-HR
Activity in Q4 2024
New Purchases 5 stocks
Additional Purchases 10 stocks
Sold out of 0 stocks
Reduced holdings in 4 stocks

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Finepoint Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Finepoint Capital LP with notifications on news.

Account

Finepoint Capital LP Portfolio Holdings